842 related articles for article (PubMed ID: 19817589)
1. Global rotavirus surveillance: determining the need and measuring the impact of rotavirus vaccines.
Widdowson MA; Steele D; Vojdani J; Wecker J; Parashar U
J Infect Dis; 2009 Nov; 200 Suppl 1():S1-8. PubMed ID: 19817589
[TBL] [Abstract][Full Text] [Related]
2. Assessing the effectiveness and public health impact of rotavirus vaccines after introduction in immunization programs.
Patel MM; Parashar UD
J Infect Dis; 2009 Nov; 200 Suppl 1():S291-9. PubMed ID: 19817612
[TBL] [Abstract][Full Text] [Related]
3. Rotavirus vaccination: cost-effectiveness and impact on child mortality in developing countries.
Atherly D; Dreibelbis R; Parashar UD; Levin C; Wecker J; Rheingans RD
J Infect Dis; 2009 Nov; 200 Suppl 1():S28-38. PubMed ID: 19817610
[TBL] [Abstract][Full Text] [Related]
4. Projected health and economic impact of rotavirus vaccination in GAVI-eligible countries: 2011-2030.
Atherly DE; Lewis KD; Tate J; Parashar UD; Rheingans RD
Vaccine; 2012 Apr; 30 Suppl 1():A7-14. PubMed ID: 22520139
[TBL] [Abstract][Full Text] [Related]
5. Costs of diarrheal disease and the cost-effectiveness of a rotavirus vaccination program in kyrgyzstan.
Flem ET; Latipov R; Nurmatov ZS; Xue Y; Kasymbekova KT; Rheingans RD
J Infect Dis; 2009 Nov; 200 Suppl 1():S195-202. PubMed ID: 19817600
[TBL] [Abstract][Full Text] [Related]
6. Economic costs of rotavirus gastroenteritis and cost-effectiveness of vaccination in developing countries.
Rheingans RD; Antil L; Dreibelbis R; Podewils LJ; Bresee JS; Parashar UD
J Infect Dis; 2009 Nov; 200 Suppl 1():S16-27. PubMed ID: 19817595
[TBL] [Abstract][Full Text] [Related]
7. Rotavirus vaccines: targeting the developing world.
Glass RI; Bresee JS; Turcios R; Fischer TK; Parashar UD; Steele AD
J Infect Dis; 2005 Sep; 192 Suppl 1():S160-6. PubMed ID: 16088799
[TBL] [Abstract][Full Text] [Related]
8. Considerations for introduction of a rotavirus vaccine in Oman: rotavirus disease and economic burden.
Al Awaidy SA; Bawikar S; Al Busaidy S; Baqiani S; Al Abedani I; Varghese R; Abdoan HS; Al Abdoon H; Bhatnagar S; Al Hasini KS; Mohan P; Shah S; Elamir E; Klena J; Ahmed SF; Teleb N; Parashar U; Patel MM
J Infect Dis; 2009 Nov; 200 Suppl 1():S248-53. PubMed ID: 19817605
[TBL] [Abstract][Full Text] [Related]
9. Health care costs of diarrheal disease and estimates of the cost-effectiveness of rotavirus vaccination in Vietnam.
Fischer TK; Anh DD; Antil L; Cat ND; Kilgore PE; Thiem VD; Rheingans R; Tho le H; Glass RI; Bresee JS
J Infect Dis; 2005 Nov; 192(10):1720-6. PubMed ID: 16235169
[TBL] [Abstract][Full Text] [Related]
10. Rotavirus epidemiology: the Asian Rotavirus Surveillance Network.
Nelson EA; Bresee JS; Parashar UD; Widdowson MA; Glass RI;
Vaccine; 2008 Jun; 26(26):3192-6. PubMed ID: 18485546
[TBL] [Abstract][Full Text] [Related]
11. Projected cost-effectiveness of rotavirus vaccination for children in Asia.
Podewils LJ; Antil L; Hummelman E; Bresee J; Parashar UD; Rheingans R
J Infect Dis; 2005 Sep; 192 Suppl 1():S133-45. PubMed ID: 16088797
[TBL] [Abstract][Full Text] [Related]
12. Rotavirus surveillance --- worldwide, 2009.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2011 Apr; 60(16):514-6. PubMed ID: 21527889
[TBL] [Abstract][Full Text] [Related]
13. Distributional impact of rotavirus vaccination in 25 GAVI countries: estimating disparities in benefits and cost-effectiveness.
Rheingans R; Atherly D; Anderson J
Vaccine; 2012 Apr; 30 Suppl 1():A15-23. PubMed ID: 22520124
[TBL] [Abstract][Full Text] [Related]
14. Rotavirus disease burden and impact and cost-effectiveness of a rotavirus vaccination program in kenya.
Tate JE; Rheingans RD; O'Reilly CE; Obonyo B; Burton DC; Tornheim JA; Adazu K; Jaron P; Ochieng B; Kerin T; Calhoun L; Hamel M; Laserson K; Breiman RF; Feikin DR; Mintz ED; Widdowson MA
J Infect Dis; 2009 Nov; 200 Suppl 1():S76-84. PubMed ID: 19817618
[TBL] [Abstract][Full Text] [Related]
15. Health economics of rotavirus immunization in Vietnam: potentials for favorable cost-effectiveness in developing countries.
Tu HA; Rozenbaum MH; Coyte PC; Li SC; Woerdenbag HJ; Postma MJ
Vaccine; 2012 Feb; 30(8):1521-8. PubMed ID: 22119590
[TBL] [Abstract][Full Text] [Related]
16. Rotavirus surveillance--worldwide, 2001-2008.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2008 Nov; 57(46):1255-7. PubMed ID: 19023263
[TBL] [Abstract][Full Text] [Related]
17. Projected health benefits and costs of pneumococcal and rotavirus vaccination in Uganda.
Tate JE; Kisakye A; Mugyenyi P; Kizza D; Odiit A; Braka F
Vaccine; 2011 Apr; 29(17):3329-34. PubMed ID: 21241733
[TBL] [Abstract][Full Text] [Related]
18. Global mortality associated with rotavirus disease among children in 2004.
Parashar UD; Burton A; Lanata C; Boschi-Pinto C; Shibuya K; Steele D; Birmingham M; Glass RI
J Infect Dis; 2009 Nov; 200 Suppl 1():S9-S15. PubMed ID: 19817620
[TBL] [Abstract][Full Text] [Related]
19. Global impact of rotavirus vaccines.
Tate JE; Patel MM; Steele AD; Gentsch JR; Payne DC; Cortese MM; Nakagomi O; Cunliffe NA; Jiang B; Neuzil KM; de Oliveira LH; Glass RI; Parashar UD
Expert Rev Vaccines; 2010 Apr; 9(4):395-407. PubMed ID: 20370550
[TBL] [Abstract][Full Text] [Related]
20. Implementing rotavirus vaccination in Asia.
Santosham M; Nelson EA; Bresee JS
Vaccine; 2007 Nov; 25(44):7711-6. PubMed ID: 17881099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
